Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11387306rdf:typepubmed:Citationlld:pubmed
pubmed-article:11387306lifeskim:mentionsumls-concept:C0043210lld:lifeskim
pubmed-article:11387306lifeskim:mentionsumls-concept:C0000786lld:lifeskim
pubmed-article:11387306lifeskim:mentionsumls-concept:C0034897lld:lifeskim
pubmed-article:11387306lifeskim:mentionsumls-concept:C0427399lld:lifeskim
pubmed-article:11387306pubmed:issue6lld:pubmed
pubmed-article:11387306pubmed:dateCreated2001-6-1lld:pubmed
pubmed-article:11387306pubmed:abstractTextA number of cases of unexplained (idiopathic) recurrent spontaneous abortions may be attributable to immunological mechanisms. Several lines of evidence indicate that some immunocompetent effector cell populations play an important role in the pathogenesis of unexplained miscarriages. However a suitable method is lacking for defining an existing immunological background of recurrent spontaneous abortions. We tried to find a useful cellular immunological method, that is suitable for predicting the eventual immunological cause in the case of unexplained recurrent spontaneous abortions. We have examined the anti-paternal cytotoxic T-lymphocyte precursor frequencies by cell-mediated lympholysis and limiting dilution analysis in the peripheral blood of women with recurrent spontaneous abortions in order to reveal the functional role of this cell population in spontaneous abortions. An extremely high partner allo-antigen-specific cytotoxic T-lymphocyte precursor frequency was determined in the case of all those habitual aborters, where no other than an immunological cause could be responsible for the abortions. This phenomenon supports the important role of the T-lymphocytes in this disorder. We suggest that the immunological background of recurrent spontaneous miscarriages might be determined on the basis of a very high cytotoxic T-lymphocyte precursor frequency. This diagnostic test might be useful in selecting patients for immunotherapy.lld:pubmed
pubmed-article:11387306pubmed:languageenglld:pubmed
pubmed-article:11387306pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11387306pubmed:citationSubsetIMlld:pubmed
pubmed-article:11387306pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11387306pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11387306pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11387306pubmed:statusMEDLINElld:pubmed
pubmed-article:11387306pubmed:monthJunlld:pubmed
pubmed-article:11387306pubmed:issn0268-1161lld:pubmed
pubmed-article:11387306pubmed:authorpubmed-author:PetrányiGGlld:pubmed
pubmed-article:11387306pubmed:authorpubmed-author:SzigetváriIIlld:pubmed
pubmed-article:11387306pubmed:authorpubmed-author:FülöpVVlld:pubmed
pubmed-article:11387306pubmed:authorpubmed-author:RétiMMlld:pubmed
pubmed-article:11387306pubmed:authorpubmed-author:KotlanBBlld:pubmed
pubmed-article:11387306pubmed:authorpubmed-author:Padányi Alld:pubmed
pubmed-article:11387306pubmed:authorpubmed-author:Gyódi Elld:pubmed
pubmed-article:11387306pubmed:authorpubmed-author:Fehér Elld:pubmed
pubmed-article:11387306pubmed:issnTypePrintlld:pubmed
pubmed-article:11387306pubmed:volume16lld:pubmed
pubmed-article:11387306pubmed:ownerNLMlld:pubmed
pubmed-article:11387306pubmed:authorsCompleteYlld:pubmed
pubmed-article:11387306pubmed:pagination1278-85lld:pubmed
pubmed-article:11387306pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11387306pubmed:meshHeadingpubmed-meshheading:11387306...lld:pubmed
pubmed-article:11387306pubmed:meshHeadingpubmed-meshheading:11387306...lld:pubmed
pubmed-article:11387306pubmed:meshHeadingpubmed-meshheading:11387306...lld:pubmed
pubmed-article:11387306pubmed:meshHeadingpubmed-meshheading:11387306...lld:pubmed
pubmed-article:11387306pubmed:meshHeadingpubmed-meshheading:11387306...lld:pubmed
pubmed-article:11387306pubmed:meshHeadingpubmed-meshheading:11387306...lld:pubmed
pubmed-article:11387306pubmed:meshHeadingpubmed-meshheading:11387306...lld:pubmed
pubmed-article:11387306pubmed:meshHeadingpubmed-meshheading:11387306...lld:pubmed
pubmed-article:11387306pubmed:meshHeadingpubmed-meshheading:11387306...lld:pubmed
pubmed-article:11387306pubmed:meshHeadingpubmed-meshheading:11387306...lld:pubmed
pubmed-article:11387306pubmed:meshHeadingpubmed-meshheading:11387306...lld:pubmed
pubmed-article:11387306pubmed:meshHeadingpubmed-meshheading:11387306...lld:pubmed
pubmed-article:11387306pubmed:meshHeadingpubmed-meshheading:11387306...lld:pubmed
pubmed-article:11387306pubmed:meshHeadingpubmed-meshheading:11387306...lld:pubmed
pubmed-article:11387306pubmed:meshHeadingpubmed-meshheading:11387306...lld:pubmed
pubmed-article:11387306pubmed:meshHeadingpubmed-meshheading:11387306...lld:pubmed
pubmed-article:11387306pubmed:year2001lld:pubmed
pubmed-article:11387306pubmed:articleTitleHigh anti-paternal cytotoxic T-lymphocyte precursor frequencies in women with unexplained recurrent spontaneous abortions.lld:pubmed
pubmed-article:11387306pubmed:affiliationDepartment Immunogenetics, National Institute of Haematology and Immunology, Budapest, H-1113, Hungary.lld:pubmed
pubmed-article:11387306pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11387306pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11387306lld:pubmed